-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EORA-101 in Opium (Opioid) Addiction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EORA-101 in Opium (Opioid) Addiction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EORA-101 in Opium (Opioid) Addiction Drug Details: EORA -101 is...
-
Product Insights
NewAddictive Disorders – Drugs In Development, 2024
Empower your strategies with our Addictive Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Addictive disorders, such as substance abuse and dependence, are common disorders that involve the overuse of alcohol and/or drugs. Addiction develops over time and is a chronic and relapsing illness. Addictive disorders are caused by multiple factors, including genetic vulnerability, environmental stressors, social pressures, individual personality characteristics and psychiatric problems. The Addictive Disorders drugs in development market research report provide comprehensive information...
-
Product Insights
NewSmoking Cessation – Drugs In Development, 2024
Empower your strategies with our Smoking Cessation – Drugs In Development, 2024 report and make more profitable business decisions. Smoking is addictive; smokers experience an uncontrollable dependence on cigarettes, and stopping can cause severe mental, emotional, or physical reactions. People addicted to smoking develop a tolerance to nicotine. Nicotine acts on acetylcholine receptors, causing the body to react to nicotine at these receptors in the same manner as it responds to acetylcholine. This leads to alterations in the activity and physiological...
-
Product Insights
NewOpium (Opioid) Addiction – Drugs In Development, 2024
Empower your strategies with our Opium (Opioid) Addiction – Drugs In Development, 2024 report and make more profitable business decisions. Opioid addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates (natural painkillers, known as endorphins). This can lead to an inability of the body to stop pain, because there are no endorphins to mask the pain initially. The degeneration...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JAB-3068 in Esophageal Squamous Cell Carcinoma (ESCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JAB-3068 in Esophageal Squamous Cell Carcinoma (ESCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JAB-3068 in Esophageal Squamous Cell Carcinoma (ESCC) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EORA-101 in Opium (Opioid) Addiction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EORA-101 in Opium (Opioid) Addiction Drug Details:EORA -101 is under development for the treatment of smoking...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Stemirac in Traumatic Spinal Cord Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Stemirac in Traumatic Spinal Cord Injury report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stemirac in Traumatic Spinal Cord Injury Drug Details: Stemirac...
-
Product Insights
Daniel Corp – Lake Eola Apartments – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Daniel Corp - Lake Eola Apartments - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
DIX Dev – VIVE on EOLA Residential Tower – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our DIX Dev - VIVE on EOLA Residential Tower - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EORA-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry EORA-101 Drug Details EORA -101 is under development for the treatment of smoking cessation...